Inhaled study drug for healthy smokers and people with COPD
Part of Lungs & breathing clinical trials.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 55 years old (for healthy volunteers and smokers) or 40 to 80 years old (for people with COPD)
- For smokers: have at least a 10 pack-year smoking history and currently smoke daily
- For people with COPD: have a doctor's diagnosis of COPD for at least 1 year and be a former smoker (quit for at least 6 months)
- Have a body weight of at least 50 kg (110 lbs) and a body mass index (BMI) between 18 and 32
- Be willing to use highly effective birth control (if you can become pregnant)
- Not have certain health conditions, infections, or abnormal blood test results (like liver or kidney issues)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new inhaled medication (HRS-9821) to see if it is safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with COPD (chronic lung disease) to understand if it might help with breathing.
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This trial tests an inhaled medication for COPD. It aims to see if the treatment is safe and helps improve breathing and symptoms.
This trial tests whether an inhaled medication called HRS-9821 can help people with moderate to severe COPD (chronic obstructive pulmonary disease) breathe better and reduce symptoms. You inhale the medication, and researchers will measure how well your lungs work and how you feel over time.
This study tests an experimental medicine called R-3750 to see if it is safe and helpful for people with mild to moderate COPD. It is an early-phase trial, so the main goal is safety, but they will also look at how your breathing responds.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.